Research Notes

Stay informed with the most recent market and company research insights.

A man sitting at a table with a glass of orange juice.

Research Notes

Performing stronger than expected

Judo Capital Holdings
3:27pm
January 23, 2024
JDO released its unaudited 1H24 result and outlook for 2H24 (and into FY25), which were ahead of expectations. We make material upgrades to forecasts to align with performance and outlook. 12 month target price lifted 8% to $1.50/share, due to forecast changes. ADD.

Executing on asset sales

Garda Property Group
3:27pm
January 23, 2024
GDF‘s focus remains on capital recycling initiatives and executing on the current development pipeline. During 1H24, GDF has executed on asset sales totalling +$100m which will be used to pay down debt and recycle into industrial developments, particularly North Lakes. Post settlement of the Botanicca 7 and 9 office assets in February, we estimate GDF’s portfolio will be valued at +$460m and will be 80% weighted towards industrial (SE QLD) with the sole office asset the Cairns Corporate Tower (BV $82m). At the upcoming result on 8 February we expect FY24 DPS guidance of 6.3c to be reiterated however likely with a higher payout ratio and FFO guidance to be lower given the timing between asset sales and new industrial developments completing. GDF usually revalues assets around April/May so updates will likely fall after the 1H result however the Richlands industrial development may be revalued prior to this (10 year lease commences 2024). We retain an Add rating with a revised price target of $1.65.

Delays to US commercial rollout

Proteomics International Laboratories
3:27pm
January 23, 2024
PIQ have released its quarterly report in concert to an institutional placement and founder sell-down however key update around US rollout disappoints, now expected in Q2CY24 (3-6 month delay). We worked under the assumption that PIQ and SHUSA remained on track for initial launch to shortly follow with the effective date for Medicare/Medicaid reimbursement, but as we’ve highlighted in the past – dealing with these larger institutions can come at cost to timelines often being less nimble and incentivised to condense timelines. We have adjusted expectations on our US commercialisation and associated risks to market penetration and roll through new share issuance. Our target price reduces to A$1.38 (from A$2.42) and we retain our Speculative Buy recommendation.

Great start to the year

Polynovo
3:27pm
January 23, 2024
PNV has provided a positive trading update for 1H24, highlighting a positive EBITDA which was a pleasant surprise and ahead of our expectations. We have increased our forecasts by ~2.0% for FY25/26. As a result our valuation and target price has increased to A$1.95 (was A$1.88). The share price has rallied over 30% in the last month and now sits within 10% of our target price and as a result we move our recommendation to Hold (from Add).

A longer period of gestation

Baby Bunting Group
3:27pm
January 23, 2024
Price competition is intense across all categories of retail at present. This presents a particular challenge for Baby Bunting as many of its products are big ticket, infrequent purchases. Price competition cost the company around $6m in lost sales in 1H24 and the operating leverage effect of this, together with the cost of investing in marketing, has weighed on earnings. We believe Baby Bunting is following the appropriate strategy to strengthen its market position, but it will take time. We have cut estimates, but we’re staying on an ADD rating with a $2.00 target price.

Model update

Rio Tinto
3:27pm
January 23, 2024
We have further updated our assumptions post RIO’s 4Q’CY23 operational result, and ahead of its CY23 earnings result on 21 February. The key changes bring us closer to consensus on H2’CY23 EBITDA after reviewing our second half unit cost assumptions for RIO’s Pilbara, bauxite and aluminium operations. Our target price remains A$128ps and our recommendation remains Hold.

Guidance demonstrates progress

Wagners
3:27pm
January 22, 2024
WGN has released a HY24 trading update and FY24 guidance, ahead of their result on 21-Feb. HY24 EBIT of $20.0m was ahead of our expectations of $15.0m, with the full year FY24 guidance of $31.0m-$34.0m beating our expectations of $30m (c.78% EBIT growth on the pcp). WGN’s 1H skew (1H24 $20.0m vs 2HFY $11m-$14m) is principally due to the completion of production of precast concrete tunnel segments for the Sydney Metro project. That said, the forecast 2HFY24 guidance is ahead of the pcp on a like-for-like basis. Given WGN’s return to growth and the strength of the underlying construction markets, we remain on a Speculative Buy, increasing our target price to $1.15/sh.

Positioned for eventual metals recovery

South32
3:27pm
January 22, 2024
S32 reported a mixed 2Q24 operational and sales result, trimming FY24 production guidance for Alumar, Mozal and molybdenum (Sierra Gorda). Second half skew on production and lower metal prices have combined for subdued 1H earnings estimates. Importantly, S32 has kept a lid on opex, reaffirming FY24 guidance. Low growth and cratering earnings, but S32 is positioned as an early potential winner from an eventual turnaround in global/China growth. We maintain an Add recommendation with an updated A$4.75ps target price.

Transformation on-track, but reflecting in price

Whitehaven Coal
3:27pm
January 19, 2024
Mixed 2Q production has a reasonably neutral impact to our overall views. Slight downgrades to FY24-25 EBITDA reflect trimmed ST NEWC assumptions Acquisition of the BMA assets is progressing strongly, but we’re cautious about dislocations in the ST met coal market and possible implications for dividends. We downgrade to Hold as WHC now trades within 10% of our revised target.

Solid first half outside of BMA

BHP Group
3:27pm
January 18, 2024
BHP delivered a result that was largely in line with expectations, albeit with BMA trailing while NSWEC surprised on the upside. We expect BHP’s interim dividend to remain at healthier levels than previously feared, with BHP guiding to lower net debt than we had expected for the half of US$12.5-$13.0bn. In great shape but trading near fair value we maintain our Hold recommendation.

News & Insights

Michael Knox, Chief Economist, reveals how the OECD and RBA’s outdated assumptions about global trade fail to account for China’s Marxist-Leninist economic strategies.

This morning, I was asked to discuss Sarah Hunter’s presentation from yesterday. Sarah, the Assistant Governor and Chief Economist at the Reserve Bank of Australia (RBA), delivered a detailed and competent discussion on the conventional view of tariffs’ impact on the international economy. She highlighted that tariffs typically increase inflation and reduce economic output, a perspective echoed by the OECD in a similar presentation overnight. Sarah’s analysis focused on the potential shocks tariffs could cause, particularly their effects on GDP and inflation.

Drawing on my experience as an Australian trade commissioner and my work in Australian embassies, I found her presentation particularly interesting. My background allowed me to bring specialist knowledge to the conversation, which I believe gave me an edge. Notably, I observed that the RBA seems to lack analysts closely tracking individual policymakers in the Trump administration, such as Scott Bessent, whose views on tariffs and competition differ from the general assumptions. The conventional view assumes a world of perfectly competitive countries adhering to international trade rules and unlikely to engage in conflict—a scenario that doesn’t align with the current global trade environment, especially between China and the United States.

China, operating as a Marxist-Leninist economy, aims to dominate global markets by building monopolies in areas like rare earths, nickel, copper, and other base metals. It maintains a managed exchange rate, despite promises to the International Monetary Fund for a freely floating currency. If China allowed its currency, the RMB, to float, it would likely appreciate significantly, increasing imports and reducing its trade surplus. This would create a more balanced international trade environment, potentially reducing the need for other countries to impose tariffs. However, major institutions like the OECD and RBA seem to misjudge the nature of this trade shock, relying on outdated assumptions about global trade dynamics.

The international community also appears to overlook specific U.S. policy intentions, such as those articulated by figures like Peter Navarro and Scott Bessent. The U.S. aims to use tariffs selectively to bolster industries like pharmaceuticals, precision manufacturing, and motor vehicles. This misunderstanding leads public institutions to perceive unspecified risks, as reflected in Sarah’s otherwise able presentation. Because the RBA and similar institutions view the world as fraught with undefined risks, they are inclined to keep interest rates low, responding to perceived threats rather than an equilibrium model.

Interestingly, data from the U.S. economy contradicts the expected negative impacts of tariffs. The Chicago Fed National Activity Indicator, a reliable gauge of economic growth since the 2008 financial crisis, shows U.S. growth above the long-term trend for the first four months of this year. This suggests resilience despite tariff-related shocks. Ideally, growth will slow later this year, prompting the Federal Reserve to cut rates, facilitating a soft landing and a decline in the U.S. dollar to boost global commodity prices. However, this nuanced outlook wasn’t evident in yesterday’s presentation.

Moreover, the anticipated rise in U.S. inflation due to tariffs isn’t materialising. Scott Bessent recently noted that U.S. CPI inflation is lower than expected, with core inflation shown as the (16% trimmed mean) at 3% for the past two months . Core inflation  excluding  food and energy CPI  is only at 2.8%. This suggests that Chinese suppliers are absorbing tariff costs to maintain market share, rather than passing them on as higher prices. Recent Chinese data supports this, showing a slight decline in manufacturing confidence and coal consumption, indicating reduced factory output and electricity use. This points to a modest slowdown in China’s economy. So far the expected negative effects on U.S. prices and output are not occurring.

In summary, the fears expressed by institutions like the RBA and OECD about the Trump administration’s trade policies appear overstated. The U.S. economy is not experiencing the predicted declines in output or increases in inflation. While these effects may emerge later, the current data suggests that the risks are not as severe as anticipated, highlighting a disconnect between theoretical models and real-world outcomes.

Read more
Michael Knox outlines the economic outlook for growth and inflation in the U.S., the Euro area, China, India, and Australia, drawing data from the International Monetary Fund, the Congressional Budget Office, European sources, and his own analysis for Australia.

Today, I’m presenting the first page of my updated presentation, which focuses on GDP growth and inflation expectations for major economies. Before diving into that, I want to clarify a point about U.S. trade negotiations that has confused some media outlets.

In the previous Trump Administration ,there was single trade negotiator, Robert Lighthizer, held a cabinet position with the rank of Ambassador. This time, to expedite negotiations and give them more weight, Trump has appointed two additional cabinet-level officials to handle trade talks with different regions. For Asian economies, Scott Bessent and Ambassador Jamison Greer, who succeeded Lighthizer and previously served on the White House staff, are managing negotiations, including those with China. For Europe, Howard Lutnick, the Commerce Secretary, and Ambassador Greer are negotiating with the European Trade Representative. When the EU representative visits Washington, D.C., they meet with Lutnick and Greer, while Chinese or Japanese representatives engage with Bessent and Greer.

In my presentation today, I’m outlining the economic outlook for growth and inflation in the U.S., the Euro area, China, India, and Australia, drawing data from the International Monetary Fund, the Congressional Budget Office, European sources, and my own analysis for Australia.

For the U.S., the best-case scenario is a soft landing, with growth slowing but remaining positive at 1.3% this year and rising to 1.7% next year. This slowdown allows the Federal Reserve to continue cutting interest rates, leading to a decline in the U.S. dollar. This in turn ,triggers a recovery in commodity prices. These prices have stabilized and are now trending upward, with an expected acceleration as the dollar weakens.

U.S. headline inflation is projected to be just below 3% next year, with higher figures this year driven by tariff effects.



Global Economic Perspective

In the Euro area, growth is accelerating slightly, from just under 1% this year to 1.2% next year, with inflation expected to hit the 2% target this year and dip to 1.9% next year.

China’s GDP growth is forecast  at 4% for both this year and next, a step down from previous 5% rates, reflecting a significant slump in domestic demand and very low inflation  Chinese Inflation is only  :   0.2% last year, 0.4% this year, and 0.9% next year.  Despite a massive fiscal push, with a budget deficit around 8% of GDP, China’s debt-to-GDP ratio is rising faster than the U.S.. Yet this is  yielding more modest  domestic growth.

India, on the other hand, continues to outperform, with 6.5% GDP growth last year, 6.2% this year, and  6.3%  next year, surpassing earlier projections.

Read more
In our International Reporting Season Review, we provide an overview of the March 2025 quarterly results season for companies in the Americas, Europe and Asia.

Positive earnings surprise

In our International Reporting Season Review, we provide an overview of the March 2025 quarterly results season for companies in the Americas, Europe and Asia. For all the volatility in markets caused by US trade policy, the results were positive. For all the 187 high profile and blue-chip companies in our International Watchlist, the median EPS beat vs consensus was 3.2%, nearly twice that recorded in the December quarter (1.8%). 37% of companies exceeded consensus EPS expectations by more than 5% and only 9% missed by more than 5%. Communication Services was the most positive sector, led by Magnificent 7 companies Alphabet and Meta Platforms. The median EPS beat in that sector was 13%. Consumer Discretionary was the biggest disappointment (though only a mild one) with EPS falling 0.6% short of analyst estimates on a median basis.

Alphabet and Meta among the best performers

Across our Watchlist, some of the best performing stocks in terms of EPS beats were Alphabet, Boeing, Uniqlo-owner Fast Retailing, Meta Platforms, Newmont and The Walt Disney Company. Notable misses came from insurance broker Aon, BP, PepsiCo, Starbucks, Tesla and UnitedHealth. The latter saw by far the worst share price performance over reporting season, its earnings weakness compounded by the resignation of its CEO and the launch of a fraud investigation by the Department of Justice. British luxury fashion label Burberry had the best performing share price as it gains traction in its turnaround plan.

Tariffs were the main talking point (of course)

The timing of President Trump’s ‘Liberation Day’ on 2 April, just before the March quarter results started rolling in, guaranteed that US tariffs would be the main talking point throughout reporting season. Most companies took the line that higher tariffs presented a material risk to global growth and inflation. The rapidly shifting sands of US trade policy mean the impact of tariffs is highly uncertain. This didn’t stop many companies from trying to estimate the impact on their profits. This ranged from the very precise ($850m said RTX) to the extremely vague (‘a few hundred million dollars’ hazarded Abbott Laboratories). The rehabilitation of AI as a systemic driver of long-term value was a key theme of reporting season, with many companies reporting what Palantir Technologies described as an ‘unstoppable whirlwind of demand’ and others indicating an increase in planned AI investment. The deterioration in consumer confidence was another key talking point, though most companies could only express concern about a possible future softening in demand rather than any actual evidence of a hit to sales.

Our International Focus List continues to outperform

In this report, we also report on the performance of the Morgans International Focus List, which is now up 25.3% since inception last year, outperforming the benchmark S&P 500 by 20.4%.


Morgans clients receive exclusive insights such as access to our latest International Reporting Season article.

Contact us today to begin your journey with Morgans.

      
Contact us
      
      
Find an adviser
      
Read more